Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration This cohort study conducted in Ontario, Canada, evaluates the risk of developing neovascular age-related macular degeneration associated with the use of glucagon-like peptide-1 receptor agonists in pa...

Uso de GLP1RA en pacientes con diabetes se asocia con un riesgo 2 veces mayor de desarrollar degeneración macular neovascular asociada con la edad #glp1ras #nAMD #diabetes jamanetwork.com/journals/jam...

16-17 GLP-1 - Weight expectations As an occupation at the very epicentre of healthcare, the nurse is a constant and iconic presence. In this edition of PharmaTimes, we demonstrate how this reassuring and essential presence within our ...

#weightlossmedications #obesity #weightmanagement #onlineprescribing #GLP1receptoragonists #GLP1RAs #Privateprescribingplatforms #GeneralPharmaceuticalCouncil #onlineprescribingplatforms #MHRA #LMCs #BMA #CQC #GLP1RAprescriptions #digitalhealthservices #nationalprescribingregistry
zurl.co/XFSNp

Abstract

#Medsky🧪 #neurosky #pharmsky #publichealth While #GLP1RAs show considerable promise, they are currently not approved for the treatment of #bipolardisorder.

📊Can #GLP1RAs provide benefits for adults with #T1D & #obesity already using #AID systems?

Prof Janet Snell-Bergeon shares results from the ADJUST-T1D trial regarding #WeightLoss, #InsulinRequirement, #GlycaemicControl.

📺Watch the latest #ExpertInsights ep. now: easd-elearning.eu/episode/343/...

📢NEW: August issue now online featuring #RSV, #GLP1RAs, #sepsis, #IBD, #cardiomyopathy, #BreastCancer, #Covid, #HIV, #stroke, and much more with our editorial on happiness and health

…all available #free, #OpenAccess❗️

Read more here: www.thelancet.com/issue/S2589-...

Attribution: Getty
#MedSky

GLP-1RAs Better Reduce Amputation Risk Than SGLT2is in T2D GLP-1RAs were associated with significantly reduced risk for amputations relative to SGLT2is among patients with type 2 diabetes.

#Amputation risk was significantly reduced among patients with #T2D who used #GLP1RAs compared with #SGLT2is.

@dgarmstrong.bsky.social @keck.usc.edu @uscsurgery.bsky.social

SGLT2 Inhibitors Reduce Osteoarthritis, Surgery Risks in T2D SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Compared with #GLP1RAs, #SGTL2Inhibitors were associated with reduced risks for #osteoarthritis and #JointReplacementSurgery among patients with #T2D.

GLP-1RA Use Warrants Nutritional, Lifestyle Changes: Joint Scientific Statement GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according to a scientific statement.

The American College of Lifestyle Medicine and others released a scientific advisory on #nutritional and #lifestyle priorities for patients using #GLP1RAs for #WeightManagement.

@lifestylemed-doc.bsky.social

GLP1-RAs May Benefit Psychiatric Outcomes, Quality of Life GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

#GLP1RAs were associated with improved #QualityOfLife metrics and #EmotionalEating behaviors among individuals with #overweight and #obesity.

@kingsioppn.bsky.social @kingscollegelondon.bsky.social @imperialcollegeldn.bsky.social @ox.ac.uk @rob-mccutcheon.bsky.social

GLP-1 RAs compared with bariatric metabolic surgery and risk of #obesity -related #cancer: an observational retrospective cohort study

This may point at additional pathways beyond weight loss in which #GLP1RAs might contribute to the decreased risk for ORC

www.thelancet.com/journals/ecl...
#MedSky

GLP-1 RAs show particular benefits in peripheral artery disease and post-acute cardiovascular events, while SGLT2is demonstrate unique advantages in ASCVD with comorbid chronic kidney disease.

academic.oup.com/ehjcvp/advan...

@escardio.bsky.social
#CardioSky #MedSky #GLP1RAs #SGLT2is #CKD #ASCVD

Mapping the effectiveness and risks of GLP-1 receptor agonists - Nature Medicine An atlas of the associations between the use of GLP-1 receptor agonists (GLP-1RAs) and 175 health outcomes reports the effectiveness and risks of GLP-1RAs compared with other antihyperglycemic…

#Benefits and #risks associated w #GLP1RAs
⬇️substance use, psychosis, seizures, dementia, coag disorders, cardiometabolic disorders, resp infections
⬆️GI disorders, hypotension, syncope, nephrolithiasis, interstitial nephritis, pancreatitis